Roche Purchases GeneWEAVE Diagnostics Firm In $425 Million Deal Swiss pharmaceutical company Roche is buying U.S. diagnostic firm GeneWEAVE for up to $425 million. Through the acquisition, Roche is said to have strengthened its presence in the antimicrobial research industry. by Rina Marie Doctor